We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

53 hedge funds and large institutions have $16.7M invested in NanoViricides in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $587K | Put options by funds: $158K

122% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 9

0.48% more ownership

Funds ownership: 0% → 0.48% (+0.48%)

7% less funds holding

Funds holding: 57 → 53 (-4)

18% less capital invested

Capital invested by funds: $20.4M → $16.7M (-$3.69M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
1.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
20
Reduced
9
Closed
8
Calls
$587K
Puts
$158K
Net Calls
+$429K
Net Calls Change
-$649K

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$1.24M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$529K
3
SIP
Stoneridge Investment Partners
Pennsylvania
+$239K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$225K
5
U
UBS
Switzerland
+$78.9K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$373K
2
BFA
BlackRock Fund Advisors
California
-$154K
3
Jane Street
Jane Street
New York
-$124K
4
Citadel Advisors
Citadel Advisors
Florida
-$84.9K
5
Millennium Management
Millennium Management
New York
-$67K

NNVC Hedge Fund Activity: Q3 2014 in Review

53 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2014, worth a combined $16.7M — down 18% from $20.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NNVC and 4 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 20 added.

The largest buyer was Northern Trust, adding an estimated $1.24M. The largest seller was Goldman Sachs, cutting an estimated $373K.

  • 53 institutional investors held NanoViricides (NNVC) as of Q3 2014, down from 57 in Q2 2014.
  • Funds reported $16.7M of NanoViricides stock for Q3 2014, down 18% quarter-over-quarter.
  • 4 funds opened new NanoViricides positions in Q3 2014 and 8 closed out, a net change of -4 holders.
  • The largest NanoViricides buyer in Q3 2014 was Northern Trust, an estimated $1.24M added.
  • The largest NanoViricides seller in Q3 2014 was Goldman Sachs, an estimated $373K sold.

Based on aggregated 13F filings for Q3 2014.